The serum levels of FGF19 were significantly elevated in PBC-AIH OS patients compared to healthy control individuals (1375.41 ± 276.31 vs. 255.94 ± 48.54 pg/mL; p = 0.001) (Figure 1(a)). This evidence concerns the gene FGF19 and primary biliary cholangitis.